Skip Navigation LinksHome | Editors' Blog | Post

Breaking: FY2022 ICD-10-CM guidelines fill in the details for post COVID-19

The FY2022 ICD-10-CM guidelines were released Monday, July 12, and include instructions for how to assign new code U09.9 (Post COVID-19 condition).
Guidelines for post COVID-19 condition can be found at I.C.1.g.1.m.
Beginning Oct. 1, when a patient shows signs of sequelae (late effects) of COVID-19 after the active infection has ended, you should code first the specific symptoms or sequelae, followed by code U09.9, according to new additions to the 2022 ICD-10-CM Official Guidelines for Coding and Reporting, released by the CDC.
The guidelines advise that coders should:
  • "Assign a code(s) for the specific symptom(s) or condition(s) related to the previous COVID-19 infection, if known, and code U09.9 (Post COVID-19 condition, unspecified). Code U09.9 should not be assigned for manifestations of an active (current) COVID-19 infection."
However, if the patient is battling a condition associated with a previous COVID infection and then develops a new active COVID-19 infection, assign code U09.9 in conjunction with code U07.1 (COVID-19). Don’t forget to also report specific conditions associated with both the previous and new acute COVID infections. The new guidelines state:
  • "Code U09.9 may be assigned in conjunction with code U07.1 (COVID-19) to identify that the patient also has a condition(s) associated with a previous COVID-19 infection. Code(s) for the specific condition(s) associated with the previous COVID-19 infection and code(s) for manifestation(s) of the new active (current) COVID-19 infection should also be assigned."
The guidelines take effect Oct. 1, along with the finalized FY2022 code set.
For more detailed coverage, see future issues of DecisionHealth newsletters.
To view the full guidelines, visit
Blog Tags: CMS, fee schedule
To comment, login here.
Reader Comments (0)


User Name:
Welcome to the new Part B News Online. If you are a returning user having trouble logging in, please click here.
Back to top